Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof
TW200838559A
Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity
WO2008070363A2
Intrabodies
BRPI0712368A2
method to inhibit tumor growth in a pediatric patient
MX2008015852A
Lyophilized formulations of anti-egfr antibodies.
BRPI0707796A2
formulation and treatment method
BRPI0707824A2
antigen-binding protein, and methods of neutralizing tyrosine kinase receptor activation, inhibiting angiogenesis, reducing tumor growth and producing an antigen-binding protein
KR20080090566A
Igf-ir antagonists as adjuvants for treatment of prostate cancer
CN101102791A
Antibodies against vascular endothelial growth factor receptor-1
WO2006042313A2
Egfr antagonist in treatment of fluid accumulation
WO2006020258A2
Novel tetravalent bispecific antibody
EP1773881A2
Inhibition of macrophage-stimulating protein receptor (ron)
PL383490A1
Human anti-epidermal growth factor receptor antibody
EP1701688A2
Methods and compositions for directing migration of neural progenitor cells
WO2005042495A1
(benzimidazol-2-yl)-phenyl-phenyl-urea compounds and methods for inhibiting heparanase activity
WO2005042496A1
(benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
WO2005037235A2
Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
WO2005030206A1
Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
